Berghof et al. said that the rate of PD-L1-positive cases in GBM was quite higher (72% in recurrent; 88% in newly diagnosed GBM) than melanoma cases (30%) and nonsmall cell lung cancer cases (25%–36%) [13]. The gene discussed is CD274; the disease is melanoma.